Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Nicole Clouse ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
A Substantially Pure Isomer Is Obvious When The Completely Pure Isomer Is Known In The Art
Many prior cases have addressed whether a pure stereoisomer is obvious when the corresponding 50/50 mixture is known in the prior art.
United States
2 Dec 2015
2
Supplier To ANDA Filer Is Not Liable For Induced Infringement Until After ANDA Approval
Shire markets a branded version of L-lysine-d-amphetamine dimesylate (LDX), an amphetamine useful for treatment of attention deficit hyperactivity disorder (ADHD).
United States
2 Nov 2015
3
Supplier To ANDA Filer Is Not Liable For Induced Infringement Until After ANDA Approval
The Federal Circuit reversed the district court's finding of induced infringement on two grounds.
United States
2 Nov 2015
4
PTAB Rejects Attempts To Expand The Scope Of CBM Review
Jazz’s patents at issue relate to methods of controlling access to a prescription drug which is prone to being abused.
United States
2 Mar 2015
5
Supreme Court Rules In Prometheus: Patent Claims Must Recite "Significantly More" Than A Law Of Nature
In a move that could have a significant impact on the fields of personalized medicine and medical diagnostics, the Supreme Court of the United States recently held claims to a blood test were invalid because they did not define patent-eligible subject matter.
United States
16 Apr 2012
Links to Result pages
 
1